ACC 2021: The DARE-19 Randomized Trial
- Видео
- О видео
- Скачать
- Поделиться
ACC 2021: The DARE-19 Randomized Trial
In this interview, Dr Mikhail Kosiborod discusses the outcomes of the Dare-19 Trial, which aimed to study the effects of dapagliflozin in COVID-19 patients with risk factors for complications. Questions: What prompted you to conduct the DARE-19 Trial? What was the design, patient population and endpoints? What are your key findings? What conclusion can be made? What are the impliactions beyond COVID-19? How should these influence practice? + What are the take-home messages? Recorded remotely from Kansas City, MO, 2021.
128 | 3 год. назад | 1 - 0
In this interview, Dr Mikhail Kosiborod discusses the outcomes of the Dare-19 Trial, which aimed to study the effects of dapagliflozin in COVID-19 patients with risk factors for complications.
Questions:
What prompted you to conduct the DARE-19 Trial?
What was the design, patient population and endpoints?
What are your key findings?
What conclusion can be made?
What are the impliactions beyond COVID-19?
How should these influence practice?
+ What are the take-home messages?
Recorded remotely from Kansas City, MO, 2021.
Чтобы скачать видео "ACC 2021: The DARE-19 Randomized Trial" передвинте ползунок вправо
- Комментарии
Комментарии ФБ